Volitionrx LTD (VNRX) SEC Filings — 2025
15 SEC filings for Volitionrx LTD (VNRX) in 2025.
Filings
- VolitionRx Relocates HQ, Adjusts Fiscal Year End — 8-K · Dec 11, 2025
- VolitionRx Narrows Losses Amid Revenue Growth, Cash Dries Up — 10-Q · Nov 13, 2025
- VolitionRx Files 8-K/A Amendment — 8-K/A · Nov 10, 2025
- Volitionrx LTD 8-K Filing — 8-K · Nov 7, 2025
- VolitionRx Ltd Enters Material Agreement, Reports Financials — 8-K · Oct 14, 2025
- VolitionRx Files 10-Q/A Amendment for Exhibit Inclusion — 10-Q/A · Aug 15, 2025
- VolitionRx Narrows Losses Amid Revenue Growth, R&D Cuts — 10-Q · Aug 14, 2025
- VolitionRx Limited Files Current Report (8-K) — 8-K · Aug 4, 2025
- VolitionRx Files 8-K: Bylaws, Shareholder Votes, Financials — 8-K · Jun 20, 2025
- VolitionRx Ltd. Q1 2025 10-Q: Assets $175M, Equity $96.1M — 10-Q · May 15, 2025
- VolitionRx Ltd Files Definitive Proxy Statement — DEF 14A · Apr 29, 2025
- VolitionRx Ltd. Enters and Terminates Material Agreements — 8-K · Apr 22, 2025
- VolitionRx Files 8-K for Regulation FD Disclosure — 8-K · Apr 4, 2025
- VolitionRx Ltd. Files 2024 Annual Report — 10-K · Mar 31, 2025
- VolitionRx Limited Files 8-K: Material Agreement & Other Events — 8-K · Mar 26, 2025